Furthermore, CXCR5 expression by CD4+ T lymphocytes, naïve CD4+ T cells, memory CD4+ T cells and CD8+ T lymphocytes was similar between both groups of MS patients, both analyzing CXCR5+ cells and MFI. This evidence concerns the gene CD8A and myeloid sarcoma.